A5047550401- SARS-CoV-2 and COVID-19 Research
- Bioinformatics and Genomic Networks
- Diabetes Management and Research
- Mobile Health and mHealth Applications
- COVID-19 Clinical Research Studies
- Adolescent and Pediatric Healthcare
- Computational Drug Discovery Methods
- Dermatological and COVID-19 studies
- Protein Degradation and Inhibitors
- Artificial Intelligence in Healthcare
- Health, Environment, Cognitive Aging
- Public Health Policies and Education
- vaccines and immunoinformatics approaches
National Center for Advancing Translational Sciences
2020-2022
National Institutes of Health
2021
American Axle & Manufacturing (United States)
2019
16.8 million SARS-CoV-2 infections in the US went undiagnosed first 6 months of pandemic compared to 3.5 diagnosed infections.
ABSTRACT Asymptomatic SARS-CoV-2 infection and delayed implementation of diagnostics have led to poorly defined viral prevalence rates. To address this, we analyzed seropositivity in US adults who not previously been diagnosed with COVID-19. Individuals characteristics that reflect the population ( n = 11,382) had COVID-19 were selected by quota sampling from 241,424 volunteers ClinicalTrials.gov NCT04334954 ). Enrolled participants provided medical, geographic, demographic, socioeconomic...
In the event of an outbreak due to emerging pathogen, time is essence contain or mitigate spread disease. Drug repositioning one strategies that has potential deliver therapeutics relatively quickly. The SARS-CoV-2 pandemic shown integrating critical data resources drive drug-repositioning studies, involving host–host, host–pathogen, and drug–target interactions, remains a time-consuming effort translates delay in development delivery life-saving therapy. Here, we describe workflow designed...
Background: Adolescents with type 1 diabetes (T1D) have higher hemoglobin A1C (HbA1c) levels than others. In general, adolescents engage text messaging (TM) and financial incentives, both associated improved outcomes. This study aimed to assess the impact of a TM intervention incentives on self-care behaviors HbA1c. Methods: A six-month randomized controlled trial compared MyDiaText™, education support application, standard care. The sample included 166 teens T1D, 12-18 years old, attending...
Purpose The purpose of this study was to determine the feasibility and functionality MyDiaText™, a website text messaging platform created support behavior change in adolescents with type 1 diabetes (T1DM) evaluate user satisfaction application. Methods This nonrandomized, prospective, pilot trial test interface MyDiaText, message system for 10- 17-year-old youths newly diagnosed T1DM. Feasibility evaluated by assessing user’s ability create profile on website. Functionality defined whether...
Abstract Motivation In the event of an outbreak due to emerging pathogen, time is essence contain or mitigate spread disease. Drug repositioning one strategies that has potential deliver therapeutics relatively quickly. The SARS-CoV-2 pandemic shown integrating critical data resources drive drug-repositioning studies, involving host-host, hostpathogen and drug-target interactions, remains a time-consuming effort translates delay in development delivery life-saving therapy. Results Here, we...